Balog A et al. Flow cytometric analysis of procalcitonin expression in human monocytes and granulocytes. (2002) IMMUNOLOGY LETTERS 0165-2478 1879-0542 84 3 199-203,
1158109
Szakcikk (Folyóiratcikk) | Tudományos[1158109]
Asano Shuichi et al. Multisystem Inflammatory Syndrome in an Adult on Hemodialysis with Markedly Elevated Procalcitonin and Ferritin Levels. (2023) INTERNAL MEDICINE 0918-2918 1349-7235 62 17 2571-2575
van der Laan et al. Comparison of Procalcitonin With Commonly Used Biomarkers and Algorithms for Evaluating Suspected Pediatric Musculoskeletal Infection in the Emergency Department. (2023) JOURNAL OF PEDIATRIC ORTHOPAEDICS 0271-6798 1539-2570 43 2 E168-E173
Xu Hua-Guo et al. Clinical utility of procalcitonin and its association with pathogenic microorganisms. (2022) CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES 1040-8363 1549-781X 59 2 93-111
Dutta Sourabh et al. Cerebrospinal fluid and plasma procalcitonin for the diagnosis of neonatal bacterial meningitis. (2022) JOURNAL OF PAEDIATRICS AND CHILD HEALTH 1034-4810 1440-1754 58 8 1425-1430
Niu M.M. et al. Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness. (2021) CLINICAL AND EXPERIMENTAL MEDICINE 1591-8890 1591-9528 21 633-643
Hincu Maura-Adelina et al. Relevance of Biomarkers Currently in Use or Research for Practical Diagnosis Approach of Neonatal Early-Onset Sepsis. (2020) CHILDREN (BASEL) 2227-9067 7 12
Zubareva Nadezhda Anatol et al. Association between Abscess Fluid and Procalcitonin in Blood Serum. (2020) JOURNAL OF EXPERIMENTAL AND CLINICAL SURGERY 2070-478X 2409-143X 13 2 109-115
Eschborn Samantha et al. Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis. (2019) JOURNAL OF PERINATOLOGY 0743-8346 1476-5543 39 7 893-903
Mangogna A. et al. Overview of procalcitonin in pregnancy and in pre-eclampsia. (2019) CLINICAL AND EXPERIMENTAL IMMUNOLOGY 0009-9104 1365-2249 198 1 37-46
Agostinis Chiara et al. Pre-eclampsia affects procalcitonin production in placental tissue. (2018) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 79 4
Choi Justin J. et al. Novel applications for serum procalcitonin testing in clinical practice. (2018) EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 1473-7159 1744-8352 18 1 27-34
Li Wen et al. Diagnostic Accuracy of Cerebrospinal Fluid Procalcitonin in Bacterial Meningitis Patients with Empiric Antibiotic Pretreatment. (2017) JOURNAL OF CLINICAL MICROBIOLOGY 0095-1137 1098-660X 55 4 1193-1204
EL-GAREM N et al. Procalcitonin as a Marker of Infection in Patients with Liver Cirrhosis Compared to C-Reactive Protein. (2016) MEDICAL JOURNAL OF CAIRO UNIVERSITY 0045-3803 2536-9806 84 2 163-167
Kiszewska N et al. Selected inflammatory markers in the diagnosis and monitoring of infections in children treated for hematological malignancies. (2015) BIOMARKERS IN MEDICINE 1752-0363 1752-0371 9 5 461-471
Hendek MK et al. Evaluation of salivary procalcitonin levels in different periodontal diseases. (2015) JOURNAL OF PERIODONTOLOGY 0022-3492 1943-3670 86 6 820-826
Rami D et al. The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro. (2014) MEDIATORS OF INFLAMMATION 0962-9351 1466-1861 2014
Tamura M et al. Serial quantification of procalcitonin (PCT) predicts clinical outcome and prognosis in patients with community-acquired pneumonia (CAP). (2014) JOURNAL OF INFECTION AND CHEMOTHERAPY 1341-321X 1437-7780 20 2 97-103
Wang C et al. Procalcitonin levels in fresh serum and fresh synovial fluid for the differential diagnosis of knee septic arthritis from rheumatoid arthritis, osteoarthritis and gouty arthritis. (2014) EXPERIMENTAL AND THERAPEUTIC MEDICINE 1792-0981 1792-1015 8 4 1075-1080
Mallamaci F et al. Procalcitonin and the inflammatory response to salt in essential hypertension: A randomized cross-over clinical trial. (2013) JOURNAL OF HYPERTENSION 0263-6352 1473-5598 31 7 1424-1430
Skirecki T et al. Sepsis immunopathology: Perspectives of monitoring and modulation of the immune disturbances. (2012) ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS 0004-069X 1661-4917 60 2 123-135
La Camera G et al. Prognostic role of procalcitonin in the early detection of patients at risk of post-operative infection. (2012) ACTA MEDICA MEDITERRANEA 0393-6384 2283-9720 28 2 95-98
Ogasawara T et al. Intrathoracic administration of OK-432 elevates the serum procalcitonin levels. (2012) INTERNAL MEDICINE 0918-2918 1349-7235 51 19 2727-2731
Matwiyoff GN et al. Immune regulation of procalcitonin: Abiomarker and mediator of infection. (2012) INFLAMMATION RESEARCH 1023-3830 1420-908X 61 5 401-409
Wei J X et al. Examination of the effect of procalcitonin on human leucocytes and the porcine isolated coronary artery. (2008) BRITISH JOURNAL OF ANAESTHESIA 0007-0912 1471-6771 100 5 612-621
Krämer P M et al. Development and characterization of new rat monoclonal antibodies for procalcitonin. (2008) ANALYTICAL AND BIOANALYTICAL CHEMISTRY 1618-2642 1618-2650 392 4 727-736
Decaluwe H et al. Procalcitonin in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome. (2006) PEDIATRIC RESEARCH 0031-3998 1530-0447 59 4 PART 1 579-583
Guz G et al. Procalcitonin and conventional markers of inflammation in peritoneal dialysis patients and peritonitis. (2006) PERITONEAL DIALYSIS INTERNATIONAL 0896-8608 1718-4304 26 2 240-248
Bucova M et al. Immunomodulatory effect of recombinant human procalcitonin on mitogenic activity of lymphocytes. (2006) CENTRAL-EUROPEAN JOURNAL OF IMMUNOLOGY 1426-3912 1644-4124 31 3-4 87-93
Bota D P et al. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. (2005) JOURNAL OF LABORATORY AND CLINICAL MEDICINE 0022-2143 1532-6543 1931-5244 146 6 347-351
Herget-Rosenthal S et al. Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. (2005) SCANDINAVIAN JOURNAL OF IMMUNOLOGY 0300-9475 1365-3083 61 2 180-186
Pinčíková T et al. Influence of recombinant human procalcitonin on phagocytic and candidacidal ability of polymorphonuclear leukocytes and on killing mechanisms of serum and blood against bacteria Staphylococcus aureus and Escherichia coli: Vplyv rekombinantného l'udského prokalcitonínu na fagocytovú a kandidacídnu schopnost' polymorfonukleárnych leukocytov a na cídne mechanizmy séra a krvi voči baktériám Staphylococcus areus a Escherichia coli. (2005) VNITRNI LEKARSTVI 0042-773X 1801-7592 51 12 1365-1370
Hoffmann G. The role of procalcitonin in sepsis and septic shock. (2004) CURRENT MEDICINAL CHEMISTRY: IMMUNOLOGY, ENDOCRINE AND METABOLIC AGENTS 1568-0134 1875-6107 4 2 143-147
Rau B et al. Procalcitonin: Improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis. (2004) LANGENBECKS ARCHIVES OF SURGERY 1435-2443 1435-2451 389 2 134-144
Linscheid P et al. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. (2004) CRITICAL CARE MEDICINE 0090-3493 1530-0293 32 8 1715-1721
Balog A et al. Investigation of the prognostic value of TNF-alpha gene polymorphism among patients treated with infliximab, and the effects of infliximab therapy on TNF-alpha production and apoptosis. (2004) PATHOBIOLOGY 1015-2008 1423-0291 71 5 274-280,
1158126
Szakcikk (Folyóiratcikk) | Tudományos[1158126]
Can Venhar Gurbuz et al. Comparative analysis of TNF-α (-308) gene polymorphism in Turkish patients with type 2 diabetes developing nephropathy and/or neuropathy. (2024) SCIENTIFIC REPORTS 2045-2322 14 1
Mohammed Samer et al. Association of tumor necrosis factor-alpha promoter region gene polymorphism at positions-308G/A,-857C/T, and-863C/A with etanercept response in Iraqi rheumatoid arthritis patients. (2022) ARCHIVES OF RHEUMATOLOGY 2148-5046 2618-6500 37 4 613-625
Salvador-Martin Sara et al. Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease. (2020) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 21 9
Davignon Jean-Luc et al. Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review. (2018) ARTHRITIS RESEARCH & THERAPY 1478-6354 1478-6362 20
Kotovskaya M. A. et al. Personalized medicine: Predictors for the efficiency of biological agent therapy for rheumatoid arthritis. (2017) SOVREMENNAYA REVMATOLOGIYA / MODERN RHEUMATOLOGY JOURNAL 1996-7012 2310-158X 11 2 4-17
Dhawan D.. Biotechnology for biomarkers: Towards prediction, screening, diagnosis, prognosis, and therapy. (2017) Megjelent: Omics Technologies and Bio-engineering: Towards Improving Quality of Life pp. 533-557
Oliver J et al. Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis. (2015) BIOMARKERS IN MEDICINE 1752-0363 1752-0371 9 6 499-512
Song GG et al. Association between TNF-α promoter -308 A/G polymorphism and rheumatoid arthritis: A meta-analysis. (2014) RHEUMATOLOGY INTERNATIONAL 0172-8172 1437-160X 34 4 465-471
Umićević Mirkov M et al. Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: Towards personalized medicine. (2013) PHARMACOGENOMICS 1462-2416 1744-8042 14 4 425-444
Scardapane A et al. TNF-α polymorphisms in juvenile idiopathic arthritis: Which potential clinical implications?. (2012) INTERNATIONAL JOURNAL OF RHEUMATOLOGY 1687-9260 1687-9279 2012
Tong Q et al. TNF-alpha-857 and-1031 polymorphisms predict good therapeutic response to TNF-alpha blockers in Chinese Han patients with ankylosing spondylitis. (2012) PHARMACOGENOMICS 1462-2416 1744-8042 13 13 1459-1467
McGeough CM et al. Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-a therapy.. (2012) RHEUMATOLOGY INTERNATIONAL 0172-8172 1437-160X 32 6 1647-1653
McGeough Cathy M. Diagnostic, Prognostic and Theranostic Biomarkers for Rheumatoid Arthritis. (2012) JOURNAL OF CLINICAL AND CELLULAR IMMUNOLOGY 2155-9899 1 S6 1-5
Emonts M et al. Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. (2011) BMC MEDICAL GENETICS 1471-2350 1471-2350 12
Ingegnoli F et al. Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature. (2011) AUTOIMMUNITY REVIEWS 1568-9972 1873-0183 10 8 460-463
Papamichaela K et al. Association of TNF and FcγRIIA gene polymorphisms with differential response to infliximab in a Greek cohort of crohn's disease patients. (2011) ANNALS OF GASTROENTEROLOGY 1108-7471 1792-7463 24 1 35-40
Pavy S et al. Tumour necrosis factor α-308G→A polymorphism is not associated with response to TNFα blockers in Caucasian patients with rheumatoid arthritis: Systematic review and meta-analysis. (2010) ANNALS OF THE RHEUMATIC DISEASES 0003-4967 1468-2060 69 6 1022-1028
Marotte H et al. Predictive biomarkers of anti-TNF alpha response in rheumatoid arthritis: Biomarqueurs prédictifs de la réponse aux anti-TNF alpha dans la polyarthrite rhumatoïde. (2010) REVUE DU RHUMATISME (EDITION FRANCAISE) 1169-8330 1768-3130 77 5 448-457
O Rielly D et al. TNF-α - 308 G/A polymorphism and responsiveness to TNF-α blockade therapy in moderate to severe rheumatoid arthritis: A systematic review and meta-analysis. (2009) PHARMACOGENOMICS JOURNAL 1470-269X 1473-1150 9 3 161-167
Tingting Z et al. Progress of tumor necrosis factor-α antagonist treatment of rheumatoid arthritis drugs genomics research (肿瘤坏死因子-α拮抗剂治疗类风湿关节炎的药物基因组学研究进展). (2009) ZHONGHUA FENGSHIBINGXUE ZAZHI / CHINESE JOURNAL OF RHEUMATOLOGY 1007-7480 12 4 856-859
Tan R et al. Genetic predictors of response to anti-tumor necrosis factor drugs in rheumatoid arthritis.. (2009) Rheumatology Reports 2036-7511 2036-752X 1 e1-e4
Potter C et al. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis. (2009) ANNALS OF THE RHEUMATIC DISEASES 0003-4967 1468-2060 68 1 69-74
Phillips A M et al. Pharmacogenetics and inflammatory bowel disease. (2008) CURRENT PHARMACOGENOMICS & PERSONALIZED MEDICINE 1875-6921 1875-6913 6 3 201-224
Coury F et al. Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy. (2008) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 0392-856X 1593-098X 26 2 234-239
Liu CY et al. Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis. (2008) MOLECULAR MEDICINE 1076-1551 1528-3658 14 9-10 575-581
Ongaro A et al. Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFÎą therapy in rheumatoid arthritis?. (2008) RHEUMATOLOGY INTERNATIONAL 0172-8172 1437-160X 28 9 901-908
Schmeling H et al. Tumour necrosis factor alpha promoter polymorphisms and etanercept therapy in juvenile idiopathic arthritis. (2007) RHEUMATOLOGY INTERNATIONAL 0172-8172 1437-160X 27 4 383-386
Rezaieyazdi Z et al. Tumour necrosis factor a -308 promoter polymorphism in patients with rheumatoid arthritis. (2007) RHEUMATOLOGY INTERNATIONAL 0172-8172 1437-160X 28 2 189-191
Lee Y H et al. Tumor necrosis factor-Îą promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: A metaanalysis. (2007) JOURNAL OF RHEUMATOLOGY 0315-162X 1499-2752 34 1 43-49
CHEN HB et al. The study of the relation between triptolide inhibits peripheral blood mononuclear cell to secret TNF α and tumour necrosis factor α gene polymorphism. (2007) ZHONGGUO MIANYIXUE ZAZHI / CHINESE JOURNAL OF IMMUNOLOGY 1000-484X 2007 1 49-52
Coenen M J et al. Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis. (2007) PHARMACOGENOMICS 1462-2416 1744-8042 8 7 761-773
Guis S et al. Influence of -308 A/G polymorphism in the tumor necrosis factor α gene on etanercept treatment in rheumatoid arthritis. (2007) ARTHRITIS AND RHEUMATISM 0004-3591 1529-0131 2326-5205 57 8 1426-1430
Castro-Santos P et al. TNFÎą genotype influences development of IgA-ASCA antibodies in Crohn's disease patients with CARD15 wild type. (2006) CLINICAL IMMUNOLOGY 1521-6616 1521-7035 121 3 305-313
Shenghao TU et al. Relationship between single nucleotide polymorphism in TNF-α gene promoter region and inibitory effects of triptolide on TNF-α production in peripheral blood mononuclear cells of healthy humans. (2006) CURRENT MEDICAL SCIENCE 2096-5230 2523-899X 26 3 347-349
Taniguchi A et al. Pharmacogenomics in the treatment of rheumatoid arthritis: Clinical implication and perspective. (2006) PERSONALIZED MEDICINE 1741-0541 1744-828X 3 2 151-163
Cronstein B N. Pharmacogenetics in the rheumatic diseases. (2006) BULLETIN OF THE NYU HOSPITAL FOR JOINT DISEASES 1936-9719 1936-9727 0018-5647 2328-4633 2328-5273 64 1-2 16-19
Lee Y H et al. Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-Îą-blockers in rheumatoid arthritis: A meta-analysis. (2006) RHEUMATOLOGY INTERNATIONAL 0172-8172 1437-160X 27 2 157-161
de Vries N et al. The response to anti-TNF-Îą treatment: Gene regulation at the bedside. (2005) RHEUMATOLOGY (UNITED KINGDOM) 1462-0324 1462-0332 44 6 705-707
Mugnier B et al. Reply to the letter by T. Lequerree al. about the editorial entitled "Factors predicting responsiveness to anti-TNF alpha therapy in patients with rheumatoid arthritis: using biotherapies rationally". (2005) JOINT BONE SPINE 1297-319X 1778-7254 72 4 347-348
Balog A et al. Tumour necrosis factor-alpha and heat-shock protein 70-2 gene polymorphisms in a family with rheumatoid arthritis. (2004) ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA 1217-8950 1588-2640 51 3 263-269,
1359977
Szakcikk (Folyóiratcikk) | Tudományos[1359977]
Mashhoor E.A. et al. Relationship Between the Bee Venom Therapy and Tumor Necrosis Factor-308 Variation in the Management of Rheumatoid Arthritis, a Prospective Study. (2023) Information Sciences Letters 2090-9551 2090-956X 12 6 2707-2714
Lim Sung Ho et al. Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis. (2022) JOURNAL OF PERSONALIZED MEDICINE 2075-4426 12 8 p. 1265
Aravilli R. Kowshik et al. The Functional Impact of Alternative Splicing and Single Nucleotide Polymorphisms in Rheumatoid Arthritis. (2021) CURRENT PHARMACEUTICAL BIOTECHNOLOGY 1389-2010 1873-4316 22 8 1014-1029
Zaghlol H.M. et al. Tumour necrosis factor gene polymorphisms in Egyptian patients with rheumatoid arthritis and their relation to disease activity and severity. (2019) CENTRAL-EUROPEAN JOURNAL OF IMMUNOLOGY 1426-3912 1644-4124 44 3 277-284
Zagloul HM et al. TUMOR NECROSIS FACTOR GENE POLYMORPHISMS AND THEIR ASSOCIATION WITH SUSCEPTIBILITY TO RHEUMATOID ARTHRITIS, DISEASE ACTIVITY AND SEVERITY. (2016) Egyptian Journal of Laboratory Medicine 1110-1873 28 1 59-70
Kempaiah Prakasha et al. Reduced Hsp70 and Glutamine in Pediatric Severe Malaria Anemia: Role of Hemozoin in Suppressing Hsp70 and NF-kappa B Activation. (2016) MOLECULAR MEDICINE 1076-1551 1528-3658 22 570-584
Chen J. et al. Polymorphism of heat shock protein 70-2 and enterocutaneous fistula in Chinese population. (2014) WORLD JOURNAL OF GASTROENTEROLOGY 1007-9327 2219-2840 20 35 12559-12565
Chen J et al. Crohn's disease and polymorphism of heat shock protein gene HSP70-2 in the Chinese population. (2013) JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 0815-9319 1440-1746 28 5 814-818
Zeng Z. et al. Association between tumor necrosis factor-α (TNF-α) promoter -308 G/A and response to TNF-α blockers in rheumatoid arthritis: A meta-analysis. (2013) MODERN RHEUMATOLOGY 1439-7595 1439-7609 23 3 489-495
